In a work involving advanced NSCLC Asian patients, the FGFR4-388Arg variant correlated with better outcome17, and in another study involving Caucasian NSCLC patients, no association between this FGFR4 variant and outcome was found18. This evidence concerns the gene FGFR4 and non-small cell lung carcinoma.